Centers For Disease Control And Prevention
Clinical trials sponsored by Centers For Disease Control And Prevention, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Needle-Free rotavirus vaccine patch enters first human tests Results expected Oct 2026 (estimated)
- Could TB treatment be cut from 6 months to 17 weeks? Results expected Dec 2026 (estimated)
-
TB prevention breakthrough? 6-Week regimen could replace months of treatment
Prevention Recruiting nowThis study compares a new 6-week daily rifapentine regimen to the standard 12-16 week rifamycin-based treatment for latent tuberculosis infection (LTBI). The goal is to see if the shorter treatment is just as safe and effective at preventing active TB. About 3,400 people at highe…
Phase 2/3 • Sponsor: Centers for Disease Control and Prevention • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
Massive national ALS registry launches to uncover disease clues
Knowledge-focused Recruiting nowThis study is building a large registry of people with ALS in the United States. The goal is to count how many people have the disease and learn about possible causes, such as environmental or genetic factors. Anyone 18 or older with ALS can join. The registry does not test a tre…
Sponsor: Centers for Disease Control and Prevention • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC